Oyster Point dry eye drug is approved, but omission in label crimps financing plan

Healthcare

An Oyster Point Pharma drug for dry eye disease has won FDA approval, the first treatment for the condition that comes as a nasal spray. In addition to that drug approval, the FDA on Monday rejected two drugs, one from Omeros and the other from United Therapeutics.

Leave a Reply